Skip to main content
SpringerLink
Log in

Infectious Complications

  • Chapter
  • First Online:
Blood and Marrow Transplant Handbook

Abstract

Infections are the most frequently occurring complications of hematopoietic stem cell transplantation (HSCT). Myelosuppressive medications, the conditioning regimen (chemotherapy, radiation therapy), mucosal damage, type of transplant, immune-suppressive therapy, and graft-versus-host disease (GvHD) all predispose the HSCT patient to life-threatening infections. Abnormal B- and T-lymphocyte function results in impaired cellular and humoral immune function. Infections that can occur in the setting of impaired cellular immunity include fungal, protozoal, and viral diseases. Humoral defects can predispose a patient to infection with pyogenic organisms and other bacteria as well as viral infections. Patients are also often hypogammaglobulinemic following transplant. Neutrophil function is impaired by the use of corticosteroids and other medications. Functional asplenia is common. The occurrence of infections in an individual patient varies due to underlying disease and immunosuppression, endogenous host flora, and pretreatment infections. Infections also vary according to the phase of the transplant process.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 59.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 79.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  • Boeckh, M. (2008). The challenge of respiratory virus infections in hematopoietic cell transplant recipients. Br J Haematol, 143:455–467.

    Google Scholar 

  • Cesaro, S., Hirsch, H.H., Faraci, M., et al. (2009). Cidofovir for BK virus-associated hemorrhagic cystitis: A retrospective study. Clin Infect Dis, 49:233–240.

    Article  CAS  PubMed  Google Scholar 

  • Emanuel, D., Cunningham, I., Jules-Elysee, K., et al. (1988). Cytomegalovirus pneumonia after bone marrow transplantation successfully treated with the combination of ganciclovir and high-dose intravenous immune globulin. Ann Intern Med, 109:777–782.

    CAS  PubMed  Google Scholar 

  • Foo, H., Gottlieb, T. (2007). Lack of cross-hepatotoxicity between voriconazole and posaconazole. Clin Infect Dis, 45:803–805.

    Article  PubMed  Google Scholar 

  • Fricker-Hidalgo, H., Bulabois, C.E., Brenier-Pinchart, M.P., et al. (2009). Diagnosis of toxoplasmosis after allogeneic stem cell transplantation: Results of DNA detection and serological techniques. Clin Infect Dis, 48:e9–e15.

    Article  PubMed  Google Scholar 

  • Hughes, W.T., Armstrong, D., Bodey, G.P., et al. (2002) 2002 guidelines for the use of antimicrobial agents in neutropenic patients with cancer. Clin Infect Dis, 34:730–751.

    Article  PubMed  Google Scholar 

  • Ison, M.G. (2006). Adenovirus infections in transplant recipients. Clin Infect Dis, 43:331–339.

    Article  PubMed  Google Scholar 

  • Jones, J.L., Kruszon-Moran, D., Wilson, M., McQuillan, G., Navin, T., McAuley, J.B. (2001). Toxoplasma gondii infection in the United States: seroprevalence and risk factors. Am J Epidemiol, 154:357–365.

    Article  CAS  PubMed  Google Scholar 

  • Kontoyiannis, D.P., Marr, K.A., Park, B.J., et al. (2010). Prospective surveillance for invasive fungal infections in hematopoietic stem cell transplant recipients, 2001–2006: Overview of the Transplant-Associated Infection Surveillance Network (TRANSNET) Database. Clin Infect Dis, 50:1091–1100.

    Article  PubMed  Google Scholar 

  • Lee, W.M., Grindle, K., Pappas, T., et al. (2007). High-throughput, sensitive, and accurate multiplex PCR microsphere flow cytometry system for large-scale comprehensive detection of respiratory viruses. J Clin Microbiol, 45:2626–2634.

    Article  CAS  PubMed  Google Scholar 

  • Ljungman, P., de la Camara, R., Cordonnier, C., et al. (2008). Management of CMV, HHV-6, HHV-7 and Kaposi-sarcoma herpes virus (HHV-8) infections in patients with hematological malignancies and after SCT. Bone Marrow Transplant, 42:227–240.

    Article  CAS  PubMed  Google Scholar 

  • Ljungman, P., de la Camara, R., Milpied, N., et al. (2002). Randomized study of valacyclovir as prophylaxis against cytomegalovirus reactivation in recipients of allogeneic bone marrow transplants. Blood, 99:3050–3056.

    Article  CAS  PubMed  Google Scholar 

  • Martino, R., Parody, R., Fukuda, T., et al. (2006). Impact of the intensity of the pretransplantation conditioning regimen in patients with prior invasive aspergillosis undergoing allogeneic hematopoietic stem cell transplantation: A retrospective survey of the Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation. Blood, 108:2928–2936.

    Article  CAS  PubMed  Google Scholar 

  • McDonald, G.B. (2006). Review article: management of hepatic disease following haematopoietic cell transplant. Aliment Pharmacol Ther, 24:441–452.

    Article  CAS  PubMed  Google Scholar 

  • Meers, S., Lagrou, K., Theunissen, K., et al. (2010). Myeloablative conditioning predisposes patients for Toxoplasma gondii reactivation after allogeneic stem cell transplantation. Clin Infect Dis, 50:1127–1134.

    Article  PubMed  Google Scholar 

  • Mermel, L.A., Allon, M., Bouza, E., et al. (2009). Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 Update by the Infectious Diseases Society of America. Clin Infect Dis, 49:1–45.

    Article  CAS  PubMed  Google Scholar 

  • Musher, B., Fredricks, D., Leisenring, W., Balajee, S.A., Smith, C., Marr, K.A. (2004). Aspergillus galactomannan enzyme immunoassay and quantitative PCR for diagnosis of invasive aspergillosis with bronchoalveolar lavage fluid. J Clin Microbiol, 42:5517–5522.

    Article  CAS  PubMed  Google Scholar 

  • Nucci, M., Anaissie, E. (2007). Fusarium infections in immunocompromised patients. Clin Microbiol Rev, 20:695–704.

    Article  CAS  PubMed  Google Scholar 

  • Pappas, P.G., Kauffman, C.A., Andes, D., et al. (2009). Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America, Clin Infect Dis, 48:503–535.

    Article  CAS  PubMed  Google Scholar 

  • Pascual, A., Calandra, T., Bolay, S., Buclin, T., Bille, J., Marchetti, O. (2008). Voriconazole therapeutic drug monitoring in patients with invasive mycoses improves efficacy and safety outcomes. Clin Infect Dis, 46:201–211.

    Article  CAS  PubMed  Google Scholar 

  • Perfect, J.R., Cox, G.M., Lee, J.Y., et al. (2001). The impact of culture isolation of Aspergillus species: A hospital-based survey of aspergillosis. Clin Infect Dis, 33:1824–1833.

    Article  CAS  PubMed  Google Scholar 

  • Reed, E.C., Bowden, R.A., Dandliker, P.S., Lilleby, K.E., Meyers, J.D. (1988). Treatment of cytomegalovirus pneumonia with ganciclovir and intravenous cytomegalovirus immunoglobulin in patients with bone marrow transplants. Ann Intern Med, 109:783–788.

    CAS  PubMed  Google Scholar 

  • Savona, M.R., Newton, D., Frame, D., Levine, J.E., Mineishi, S., Kaul, D.R. (2007). Low-dose cidofovir treatment of BK virus-associated hemorrhagic cystitis in recipients of hematopoietic stem cell transplant. Bone Marrow Transplant, 39:783–787.

    Article  CAS  PubMed  Google Scholar 

  • Schmidt, G.M., Kovacs, A., Zaia, J.A., et al. (1988). Ganciclovir/immunoglobulin combination therapy for the treatment of human cytomegalovirus-associated interstitial pneumonia in bone marrow allograft recipients. Transplantation, 46:905–907.

    Article  CAS  PubMed  Google Scholar 

  • Smith, J., Andes, D. (2008). Therapeutic drug monitoring of antifungals: pharmacokinetic and pharmacodynamic considerations. Ther Drug Monit, 30:167–172.

    Article  CAS  PubMed  Google Scholar 

  • Sobel, J.D., Bradshaw, S.K., Lipka, C.J., Kartsonis, N.A. (2007). Caspofungin in the treatment of symptomatic candiduria. Clin Infect Dis, 44:e46–49.

    Article  Google Scholar 

  • Spellberg, B., Walsh, T.J., Kontoyiannis, D.P., Edwards, J. Jr., Ibrahim, A.S. (2009). Recent advances in the management of mucormycosis: from bench to bedside. Clin Infect Dis, 48:1743–1751.

    Article  CAS  PubMed  Google Scholar 

  • Styczynski, J., Einsele, H., Gil, L., Ljungman, P. (2009). Outcome of treatment of Epstein-Barr virus related post-transplant lymphoproliferative disorder in hematopoietic stem cell recipients: A comprehensive review of reported cases. Transpl Infect Dis, 11:383–392.

    Article  CAS  PubMed  Google Scholar 

  • Sun, H.Y., Wagener, M.M., Singh, N. (2009). Cryptococcosis in solid-organ, hematopoietic stem cell, and tissue transplant recipients: evidence-based evolving trends. Clin Infect Dis, 48:1566–1576.

    Article  PubMed  Google Scholar 

  • Tomblyn, M., Chiller, T., Einsele, H., et al. (2009). Guidelines for preventing infectious complications among hematopoietic cell transplantation recipients: a global perspective. Biol Blood Marrow Transplant, 15:1143–1238.

    Article  CAS  PubMed  Google Scholar 

  • Walsh, T.J., Anaissie, E.J., Denning, D.W., et al. (2008). Treatment of aspergillosis: clinical practice guidelines of the Infectious Diseases Society of America. Clin Infect Dis, 46:327–360.

    Article  CAS  PubMed  Google Scholar 

  • Weinstock, D.M., Ambrossi, G.G., Brennan, C., Kiehn, T.E., Jakubowski, A. (2006). Preemptive diagnosis and treatment of Epstein-Barr virus-associated post transplant lymphoproliferative disorder after hematopoietic stem cell transplant: an approach in development. Bone Marrow Transplant, 37:539–546.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Infectious Disease, Oregon Health and Science University, Portland, OR, USA

    Lynne Strasfeld MD

Authors
  1. Lynne Strasfeld MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Center for Hematologic Malignancies, Knight Cancer Institute, Oregon Health & Science University, Portland, 97239, Oregon, USA

    Richard T. Maziarz

  2. Center for Hematologic Malignancies, Knight Cancer Institute, Oregon Health & Science University, Portland, 97239, Oregon, USA

    Susan Slater

Rights and permissions

Reprints and permissions

Copyright information

© 2010 Springer Science+Business Media, LLC

About this chapter

Cite this chapter

Strasfeld, L. (2010). Infectious Complications. In: Maziarz, R., Slater, S. (eds) Blood and Marrow Transplant Handbook. Springer, New York, NY. https://doi.org/10.1007/978-1-4419-7506-5_14

Download citation

  • DOI: https://doi.org/10.1007/978-1-4419-7506-5_14

  • Published:

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-1-4419-7505-8

  • Online ISBN: 978-1-4419-7506-5

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation